Latest news with #innovator
Yahoo
a day ago
- Business
- Yahoo
ScanTech AI Secures ECAC Allocation to Complete European Certification for Advanced AI-Powered Explosive Detection in Aviation
Milestone Advances Global Expansion Strategy and Opens European Market Access for Sentinel CT Security Screening Systems Atlanta, GA, June 04, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI), a leading innovator in advanced security screening technologies, today announced that it has secured a formal allocation to complete the European Civil Aviation Conference (ECAC) certification process for its advanced Sentinel Fixed-Gantry CT system, designed for high-accuracy explosive detection in aviation environments. This allocation positions the Company to undergo additional Phase testing under ECAC's Common Evaluation Process of Security Equipment (CEP), a critical step toward achieving European approval for deployment at airports across the European Union and beyond. About ScanTech AI ScanTech AI Systems Inc. (Nasdaq: STAI) has developed one of the world's most advanced non-intrusive 'fixed-gantry' CT screening technologies. Utilizing proprietary artificial intelligence and machine learning capabilities, ScanTech AI's state-of-the-art scanners accurately and quickly detect hazardous materials and contraband. Engineered to automatically locate, discriminate, and identify threat materials and items of interest, ScanTech AI's solutions are designed for use in airports, seaports, borders, embassies, corporate headquarters, government and commercial buildings, factories, processing plants, and other facilities where security is a priority. For more information, visit and Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended ('Exchange Act'), including statements regarding ScanTech AI's management team's expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding the future, including possible business combinations, revenue growth and financial performance, product expansion and services. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Additionally, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'intend,' 'plan,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'ongoing,' 'target,' 'seek' or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on the current expectations and beliefs made by the management of ScanTech AI, in light of their respective experience and their perception of historical trends, current conditions and expected future developments and their potential effect on ScanTech AI, as well as other factors they believe are appropriate under the circumstances. There can be no assurance that future developments affecting ScanTech AI will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including product and service acceptance, regulatory oversights, research and development success, and that ScanTech AI will have sufficient capital to operate as anticipated. Should one or more of these risks of uncertainties materialize, or should any of the assumptions of ScanTech AI prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Additional factors that could cause actual results to differ are discussed under the heading 'Risk Factors' and in other sections of the filings of ScanTech AI (and its predecessor, Mars) with the U.S. Securities and Exchange Commission (the 'SEC'), and in the current and periodic reports filed or furnished by ScanTech AI (and its predecessor, Mars) from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on the information available to ScanTech AI as of the date hereof, and ScanTech AI assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as may otherwise be required under applicable securities laws. Contact:ScanTech AI Systems White, CFOjwhite@ Investor & Media Relations Contact:International Elite Capital Inc. Annabelle Zhang +1(646) 866-7928 annabelle@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
IOL News
4 days ago
- Business
- IOL News
SA wants bold financial reforms to end Africa's debt crisis ahead of UN financing conference
Deputy Minister of the Department of International Relations and Cooperation, Alvin Botes, said that debt must be sustainable and international development finance needs to be reimagined so that 'no school, clinic or innovator's dream is sacrificed on the altar of debt or indifference'. Image: Katlholo Maifadi / DIRCO News South Africa is calling for the upcoming 4th International Conference on Financing for Development (FfD4) to be a catalyst for change in how international development finance is structured so that no African nation suffers crippling aid debt. Deputy Minister of the Department of International Relations and Cooperation, Alvin Botes, said that debt must be sustainable and international development finance needs to be reimagined so that 'no school, clinic or innovator's dream is sacrificed on the altar of debt or indifference'. FfD4, to be held in Seville, Spain between June 30 and July 3, 'must close the financial divide, attack inequality at its root and operationalise the Pact for the Future and the Global Digital Compact,' said Botes. FfD4, to be held under the auspices of the United Nations, seeks to address the urgent need to fully implement Sustainable Development Goals (SDGs) and support reform of the international financial architecture. Speaking at an event on illicit financial flows, mobilising domestic resources, and financing for development, hosted at SGN Grant Thornton's offices towards the end of last week, Botes also said that the global financing landscape is in disrepair. 'The G20 Common Framework has stalled, multilateral development banks deliver net negative flows, and unsustainable debt crowds out SDG spending,' the Deputy Minister said. South Africa, currently Presiding over the G20 until it hands the baton to the United States at the end of November, is ready to champion developing nations when it comes to their economic plight and unsustainable debt, said Botes. He noted that 43 of the world's 47 emerging nations are in Africa. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Next Stay Close ✕ 'The age of incrementalism has ended; the era of decisive, equitable and bold action begins now. South Africa is ready to lead, to support and to walk alongside every partner committed to justice, equity and shared progress,' Botes said. South Africa aims to use its Presidency to have the G20's Common Framework overhauled some five years after its creation during the COVID-19 pandemic as a mechanism to help relieve the economic impact caused by the plague. 'South Africa chairs this G20 year resolved to turn analysis into action and global consensus into ground-level change,' said Botes. Current international development financial frameworks are throttling emerging countries, which end up with unsustainable debt that 'crowds out' SDG spending, said Botes. He added that emerging markets need to 'participate equally in global decisions'. Botes also called for multilateral development banks to honour country ownership, credit rating agencies to reflect each country's fundamentals in their assessments and not prejudice them, and for developed economies to finally meet their Overseas Development Assistance and climate-finance commitments.
&w=3840&q=100)
First Post
6 days ago
- Business
- First Post
Biotech and AI: Is Trump shooting in America's tech foot? China surging ahead of US
The US's policy under the Second Donald Trump Administration has undergone major changes, with experts saying that America is ceding tech dominance to China, which is now aiming to become from imitator to innovator read more Despite President Trump's pledges to boost American dominance in artificial intelligence (AI) and biotechnology, recent policy moves risk undermining US leadership just as China surges ahead. Trump's administration has imposed sweeping restrictions on the export of critical chip design software and advanced semiconductors to China, aiming to choke off Beijing's access to the tools needed for cutting-edge AI development. However, these curbs have prompted China to double down on its domestic innovation efforts, accelerating the development of home-grown AI chips and large language models, and pushing for self-sufficiency in key technologies. STORY CONTINUES BELOW THIS AD At the same time, US funding cuts and freezes for biomedical research—especially at the NIH—are raising alarms among experts, who warn that this could stifle early-stage biotech innovation and allow China to set the pace in life sciences. China now conducts more clinical trials than the US and is rapidly becoming a linchpin in global drug development, licensing new discoveries to American companies and leveraging a decade-long national strategy to dominate biopharma. As the US tightens controls and reduces public investment, it risks 'shooting itself in the tech foot,' potentially ceding ground to China in both biotech and AI at a critical moment in the global innovation race. What's happening in China The world is seeing a big change in science leadership: China has passed US in the number of clinical trials. This is a critical moment in the global race to lead in biotechnology. China's rise is the result of many years of government support, many trained researchers with PhDs, and more use of artificial intelligence (AI) in research. These efforts have helped China move from copying others to leading in biotech innovation. The Wall Street Journal reports that Chinese companies, which used to only make copies of Western medicines, are now creating new treatments and selling them to big international drug companies. A key moment in this shift was Pfizer's recent deal with China's 3SBio Inc. Pfizer agreed to licence a cancer drug called SSGJ-707 for over $6 billion. The deal includes a $1.25 billion upfront payment, up to $4.8 billion in future payments based on progress and a $100 million investment in 3SBio's stock. China's growth in biotech didn't happen on its own. Bayer, a global drug company, has started a life sciences incubator in Shanghai. This shows how much Bayer values China's growing pool of talent and its low-cost, creative way of doing research. Bayer's head of development, Dr Juergen Eckhardt, said Chinese companies are 'getting more and more competitive'. Many people in the pharma investment world agree. STORY CONTINUES BELOW THIS AD Licensing flows reversed: From copying to leading Pfizer's landmark licensing deal is not an outlier. It is part of a fast-expanding trend of Western companies sourcing cutting-edge drug candidates from China. Investment bank Stifel noted that approximately 30 per cent of all licensing deals by major pharma companies in 2023 and 2024 involved Chinese biotech firms, up from just 12 per cent in previous years. This reversal signals a major transformation: China is no longer merely copying Western drugs — it is now creating them. US-based venture capitalists have responded swiftly. Firms like SR One and Lux Capital are not just investing in Chinese biotech but are reorienting their business strategies around it. SR One has built a three-pronged China strategy that includes acquiring Chinese assets, encouraging clinical trials in Asia, and spinning off startups based on Chinese research. According to SR One's CEO Dr Simeon George, some of the molecules being developed in China are 'world-class,' compelling US firms to rethink how and where they place their bets. Verdiva Bio, a UK startup backed by global investors including Forbion and General Atlantic, recently raised $411 million to develop anti-obesity drugs licensed from China's Sciwind Biosciences. This is a telling example of how Chinese innovation is now forming the backbone of new ventures across borders. US slips while China surges Amid China's ascendancy, many American scientists and industry leaders worry that Washington is undermining its own future. In contrast to Beijing's long-term planning, US policy under the Trump administration has leaned toward budget tightening and regulatory overreach, particularly in biomedical funding. Bipartisan commissions have warned that America is ceding ground in what is now a globally strategic domain. These experts argue that the US needs urgent investment and greater coordination in biotech to prevent a long-term erosion of leadership. Yet the response so far has been tepid. The country's fragmented research funding, slow approval timelines and political gridlock have created an increasingly uncompetitive environment. STORY CONTINUES BELOW THIS AD Meanwhile, China is conducting faster, more cost-effective clinical trials thanks to a large population pool and efficient regulatory processes. US investors, like David Yang of Lux Capital, noted that Chinese labs are quicker to act on promising research. Export curbs backfire in AI battle On another front, AI — a core driver of biotech innovation — has become the centre of escalating tech tensions between the US and China. The Biden-era export restrictions on high-end chips from Nvidia have been fully embraced and continued under President Donald Trump. These curbs, meant to prevent China from developing advanced military AI capabilities, are instead spurring massive Chinese efforts to build indigenous alternatives. Nvidia CEO Jensen Huang has criticised the export controls, warning they jeopardise not just US corporate revenues but also long-term strategic influence. In a recent interview with CNBC, Jensen pointed out that China houses half of the world's AI researchers, forming a vast developer ecosystem that is essential for maintaining a global tech edge. He said that cutting off such a large market undercuts America's soft power in tech. The numbers are staggering. Jensen estimated that Nvidia has already lost $8 billion in sales due to the controls, with up to $50 billion annually at stake. He described China as a '$50 billion-a-year opportunity' that could help the US balance its trade deficit and create thousands of high-paying jobs. But the policy, focussed on national security over commerce, has prioritised caution over cash flow. STORY CONTINUES BELOW THIS AD China's response: De-Americanise the tech stack Beijing has not taken the restrictions passively. Instead, it has accelerated its campaign to 'de-Americanise' its technology stack, as declared by President Xi Jinping at an April Politburo study session. The Chinese leader called for breakthroughs in fundamental AI research, domestically produced chips, and software platforms that are independent from Western influence. Sinocism's Bill Bishop noted that Xi's statement clearly signaled an intent to remove US companies like Nvidia from the core of China's digital infrastructure. The strategy aligns with national security goals and longer-term economic sovereignty. Though China's domestic chips still lag behind Nvidia in performance, the government's resolve — and deep coffers — have launched an all-out sprint toward tech self-sufficiency. This means that even if export curbs are relaxed, American companies may have already lost their window of dominance. Nvidia's market share in China, which once stood at 95 per cent, has dropped to 50 per cent and continues to shrink as local competitors like Huawei scale up. Strategic technologies in a Cold War framework Both biotech and AI are now viewed through the lens of national security, not just economic competitiveness. The new tech cold war pits China's long-term, state-driven strategies against America's market-based, often short-term policymaking. The stakes are existential. As AI becomes the engine behind breakthroughs in drug development, materials science and military applications, whoever leads in these fields may shape the rules of the 21st century. Jensen, while highlighting Nvidia's loyalty to US interests, warned that technological dominance cannot be ensured by sanctions alone. Instead, sustained investment in domestic innovation, workforce development and global alliances are needed. 'We want the world to build on American technology stack,' he told CNBC's Jim Cramer. But cutting off half the world's AI developers — in China — from those platforms could prove to be a self-inflicted wound. STORY CONTINUES BELOW THIS AD In biotech, the story is no different. Licensing deals from Chinese firms are already reshaping Western pharmaceutical pipelines. US hesitancy or regulatory isolationism could end up bolstering China's global position further, as both partners and competitors increasingly look East. Call for US action grows louder With bipartisan commissions sounding the alarm, pressure is mounting for Washington to counter China's advances not with bans, but with bold initiatives. These groups are urging a Manhattan Project-scale investment in biotechnology, citing the sector's potential to transform not only medicine but also national security and economic productivity. They are calling for coordinated action across federal agencies, enhanced public-private partnerships and more resilient supply chains. But such a response requires strategic patience — something Washington rarely musters. In contrast, China's leadership is playing the long game, aligning its research, education and industrial policy with an unwavering focus on tech supremacy. If current trends continue, the US risks losing its innovation edge not because China is stealing it, but because America is neglecting it. Trump's policies, while rooted in legitimate national security concerns, may be inadvertently accelerating China's rise by walling off critical markets, talent and partnerships. The verdict: Who's winning the future? The global contest for biotech and AI leadership is no longer speculative — it's already playing out in clinical labs, investment firms and code repositories. China, with its concerted push toward innovation and self-sufficiency, appears to be pulling ahead. The US, meanwhile, risks handicapping itself through underfunding, isolationist trade policies and a lack of cohesive vision. Pfizer's partnership with 3SBio, Nvidia's lost billions and Xi's tech directives all tell a consistent story: the balance of power in high technology is shifting. Whether the US regains its footing or allows this slip to become a fall depends on the choices it makes now. STORY CONTINUES BELOW THIS AD
Business Wire
22-05-2025
- Business
- Business Wire
Scientifically Tested & Certified: Alen Air Purifiers Stand Alone To Meet the Highest Air Quality Standards
AUSTIN, Texas--(BUSINESS WIRE)-- Alen, a leading innovator in the air purification industry, today announced its air purifiers have earned multiple prestigious certifications that further validate its position of providing the 'best in class' features all air purifiers should have: a 99.9% removal of airborne allergens, maximum energy efficiency, and ultra quiet operation. Alen's air purifiers have earned certifications from Quiet Mark, the Asthma & Allergy Friendly® Certification Program, SleepScore Labs, and ENERGY STAR®, ensuring its trusted name among discerning consumers who demand high-performance air purification solutions. 'Not all air purifiers meet industry certification guidelines. Alen's air purifiers do,' said Alen CEO Warburg Lee. "Savvy consumers know us, and we're pleased that a new generation understands the importance of third-party validation to help make the best decision to ensure the well-being of their families, friends and customers.' Alen's top industry certifications include: Asthma & Allergy Friendly® Certification – Certified by Allergy Standards and the Asthma and Allergy Foundation of America. Alen's purifiers are independently tested against strict standards and proven to reduce airborne allergens, helping the more than 100 million people living in the U.S. affected by asthma and allergies annually to breathe clean air. "By removing 99.9% of airborne allergens—such as pollen, dust, and pet dander—Alen's purifiers help support a cleaner, healthier indoor environment." Quiet Mark Certification – Alen's air purifiers are engineered to deliver ultra-quiet operation, earning recognition from Quiet Mark for providing powerful purification without disruptive noise. Since loud air purifiers are often turned off, this certification ensures Alen's models help maintain clean air while supporting a peaceful environment. Quiet Mark is awarded to the top 10% to 20% of the quietest products in each category. ENERGY STAR® Certification – ENERGY STAR-certified room air purifiers use 25% less energy, on average, compared to standard models, leading to significant cost savings and reduced environmental impact. Most Alen purifiers operate using the equivalent energy of a lightbulb per day or less, with maximum wattages of 55W for the 75i, 50W for the 45i, and 40W for the 35i; however, because Alen owners rarely run their units continuously on the top fan speed, actual energy consumption can be significantly lower than these maximum values. SleepScore Validated – Scientifically validated to improve sleep quality, Alen air purifiers create cleaner indoor air for a healthier and more restful sleep environment. SleepScore Labs studies show study participants who used Alen air purifiers experienced improved sleep quality, including falling asleep faster and waking up less frequently during the night. Alen purifiers help mask disruptive sounds, promoting deeper, uninterrupted sleep and enhancing overall sleep quality by utilizing pink noise. Additionally, the TITAN Innovation Awards named Alen a Gold winner in the 2025 TITAN Innovation Awards, recognized in the Innovation in Technology and Consumer Technology category. The TITAN Innovation Awards received over 3,000 entries from more than 30 countries, reinforcing its reputation as a leading international competition for technology and design excellence. The award reflects Alen's strong commitment to advancing product innovation and technology. To learn more about Alen air purifiers and their industry recognition, visit About Alen Alen is an Austin-based innovator of high-performance air purifiers, committed to creating healthier indoor environments through advanced, scientifically validated technology. Alen's purifiers use True HEPA filters and are independently certified by Quiet Mark, the Asthma & Allergy Friendly® Certification Program, SleepScore Labs, and ENERGY STAR® for delivering best-in-class air purification, energy efficiency, ultra-quiet operation, and improved sleep quality. Alen's mission to enhance quality of life in homes, workplaces, and shared spaces is driven by the belief that wellness begins with pure air. Alen empowers individuals and families to lead healthier lives with cleaner, safer air and greater peace of mind through proprietary features like airID smart sensor technology and a commitment to lifetime reliability.
Yahoo
22-05-2025
- Health
- Yahoo
Scientifically Tested & Certified: Alen Air Purifiers Stand Alone To Meet the Highest Air Quality Standards
Recognized by Quiet Mark, Asthma & Allergy Friendly® Certification Program, SleepScore Labs, and ENERGY STAR® for superior performance AUSTIN, Texas, May 22, 2025--(BUSINESS WIRE)--Alen, a leading innovator in the air purification industry, today announced its air purifiers have earned multiple prestigious certifications that further validate its position of providing the "best in class" features all air purifiers should have: a 99.9% removal of airborne allergens, maximum energy efficiency, and ultra quiet operation. Alen's air purifiers have earned certifications from Quiet Mark, the Asthma & Allergy Friendly® Certification Program, SleepScore Labs, and ENERGY STAR®, ensuring its trusted name among discerning consumers who demand high-performance air purification solutions. "Not all air purifiers meet industry certification guidelines. Alen's air purifiers do," said Alen CEO Warburg Lee. "Savvy consumers know us, and we're pleased that a new generation understands the importance of third-party validation to help make the best decision to ensure the well-being of their families, friends and customers." Alen's top industry certifications include: Asthma & Allergy Friendly® Certification – Certified by Allergy Standards and the Asthma and Allergy Foundation of America. Alen's purifiers are independently tested against strict standards and proven to reduce airborne allergens, helping the more than 100 million people living in the U.S. affected by asthma and allergies annually to breathe clean air. "By removing 99.9% of airborne allergens—such as pollen, dust, and pet dander—Alen's purifiers help support a cleaner, healthier indoor environment." Quiet Mark Certification – Alen's air purifiers are engineered to deliver ultra-quiet operation, earning recognition from Quiet Mark for providing powerful purification without disruptive noise. Since loud air purifiers are often turned off, this certification ensures Alen's models help maintain clean air while supporting a peaceful environment. Quiet Mark is awarded to the top 10% to 20% of the quietest products in each category. ENERGY STAR® Certification – ENERGY STAR-certified room air purifiers use 25% less energy, on average, compared to standard models, leading to significant cost savings and reduced environmental impact. Most Alen purifiers operate using the equivalent energy of a lightbulb per day or less, with maximum wattages of 55W for the 75i, 50W for the 45i, and 40W for the 35i; however, because Alen owners rarely run their units continuously on the top fan speed, actual energy consumption can be significantly lower than these maximum values. SleepScore Validated – Scientifically validated to improve sleep quality, Alen air purifiers create cleaner indoor air for a healthier and more restful sleep environment. SleepScore Labs studies show study participants who used Alen air purifiers experienced improved sleep quality, including falling asleep faster and waking up less frequently during the night. Alen purifiers help mask disruptive sounds, promoting deeper, uninterrupted sleep and enhancing overall sleep quality by utilizing pink noise. Additionally, the TITAN Innovation Awards named Alen a Gold winner in the 2025 TITAN Innovation Awards, recognized in the Innovation in Technology and Consumer Technology category. The TITAN Innovation Awards received over 3,000 entries from more than 30 countries, reinforcing its reputation as a leading international competition for technology and design excellence. The award reflects Alen's strong commitment to advancing product innovation and technology. To learn more about Alen air purifiers and their industry recognition, visit About Alen Alen is an Austin-based innovator of high-performance air purifiers, committed to creating healthier indoor environments through advanced, scientifically validated technology. Alen's purifiers use True HEPA filters and are independently certified by Quiet Mark, the Asthma & Allergy Friendly® Certification Program, SleepScore Labs, and ENERGY STAR® for delivering best-in-class air purification, energy efficiency, ultra-quiet operation, and improved sleep quality. Alen's mission to enhance quality of life in homes, workplaces, and shared spaces is driven by the belief that wellness begins with pure air. Alen empowers individuals and families to lead healthier lives with cleaner, safer air and greater peace of mind through proprietary features like airID smart sensor technology and a commitment to lifetime reliability. View source version on Contacts Media Inquiries Tiffany Rodriguez310-824-9000media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
